Pfizer's Reconsideration Bid Nixed In Securities Suit
The court overseeing a putative securities class action against Pfizer Inc. has rejected the defendants' request for reconsideration of its prior ruling on a motion to dismiss, holding that Pfizer's bid...To view the full article, register now.
Already a subscriber? Click here to view full article